Fig. 2From: Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplificationIdentification of MET and HER2 amplifications in lung cancers. The analysis of focal amplifications in lung adenocarcinoma (LUAD; n = 494) and lung squamous cell carcinoma (LUSC; n = 492). The Cancer Genomic Atlas samples identify focal gains of MET and HER2 that are specific to the LUADBack to article page